Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Time to Sell?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s share price gapped down prior to trading on Thursday . The stock had previously closed at $9.70, but opened at $9.32. Curaleaf shares last traded at $9.6313, with a volume of 5,990 shares trading hands.

Wall Street Analyst Weigh In

Separately, Zacks Research lowered shares of Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy”.

Curaleaf Trading Down 0.8%

The business’s 50-day simple moving average is $7.63 and its two-hundred day simple moving average is $7.51. The firm has a market capitalization of $2.24 billion, a price-to-earnings ratio of -24.67 and a beta of 1.51. The company has a quick ratio of 0.74, a current ratio of 1.56 and a debt-to-equity ratio of 1.05.

Curaleaf (OTCMKTS:CURLF) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.27 EPS for the quarter, topping the consensus estimate of ($0.24) by $0.51. The firm had revenue of $324.23 million for the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. Equities analysts forecast that Curaleaf Holdings, Inc. will post -0.31 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.